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Abstract: According to the current model of the basal ganglia organization, simultaneous activation of the striato-nigral 
direct pathway by glutamatergic and dopaminergic neurotransmission should lead to a synergistic facilitatory action on 
locomotor activity, while in contrast activation of the indirect pathway by these two neurotransmittions should lead to an-
tagonistic effects on locomotor activity. Based on published data, as a break with the current thinking, we propose a 
reconceptualization of functional interactions between dopaminergic and glutamatergic neurotransmission. In this model, 
dopaminergic neurotransmission is seen as a motor pacemaker responsible for the basal and primary activation of striatal 
output neurons and glutamate as a driver providing a multiple combination of tonic, phasic, facilitatory and inhibitory in-
fluxes resulting from the processing of environmental, emotional and mnesic stimuli. Thus, in the model, glutamate-coded 
inputs would allow tuning the intrinsic motor-activating properties of dopamine to adjust the production of locomotor ac-
tivity into goal-oriented movements.
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tum. 
1. FUNCTIONAL NEUROANATOMY BETWEEN 
GLUTAMATERGIC AND DOPAMINERGIC NEURO-
TRANSMISSION IN THE STRIATUM COMPLEX 
(FIGS. 1 & 2) 
  The striatum including its dorsal and ventral parts, re-
spectively the caudate-putamen and the nucleus accumbens, 
is the major input structure of the basal ganglia, which are a 
set of subcortical structures that is now widely accepted to 
contribute not only to the control of motor activity and 
movements but also to the processing of cognitive and ‘lim-
bic’ (emotional and motivational) functions.While the motor 
system directly mediates the production of movements, the 
limbic system is involved in the elaboration of emotions and 
motivations, which basic drives can influence the production 
of movements and therefore the pertinence and efficacy of 
actions and goal-oriented behaviors [39,42]. Within the 
framework of interactions between the limbic system and the 
motor system, the nucleus accumbens, which corresponds to 
the limbic striatum, is considered to be a critical interface 
between the motor system and the limbic system in the brain. 
While the shell of the nucleus accumbens is generally 
thought to be associated more particularly with visceral re-
sponses, the core of the nucleus accumbens, which possesses 
similarities with the dorsal striatum (i.e. the caudate-puta-
men) both in terms of motor functions and connectivity, is 
believed to be allied more with motor functions [8,42]. 
  From an anatomofunctional point of view, the striatum 
complex receives neuronal projections from all areas of the 
cerebral cortex and from limbic and other brain structures.  
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These inputs originating from the cerebral cortex, the centro-
median and parafascicularis nucleus of the thalamus, the 
hippocampus, and the amygdala are excitatory and use glu-
tamate as a neurotransmitter. These inputs converge to the 
limbic and motor striatum where they make synaptic con-
tacts at pre- and postsynaptic levels with striatal spiny output 
neurons [29,32,69,70] and striatal aspiny GABAergic and 
cholinergic interneurons [47,52]. In addition to these excita-
tory inputs, further inputs from outside and from within the 
striatum provide additional neuronal influxes, the function of 
which is thought to modify the responsiveness of striatal 
projection neurons to glutamateric inputs. Among the in-
fluxes originating from outside the striatum are dopaminer-
gic inputs from the substantia nigra pars compacta, the ven-
tral tegmental area, and the retrorubral nucleus [31,61], as 
well as serotoninergic inputs from the raphe nuclei [79]. Fur-
ther evidence supporting such a dual regulation of striatal 
projection neurons is that glutamatergic and dopaminergic 
terminals directly converge on the dendritic spines of the 
same striatal projection neurons [13,69]. Like striatal output 
neurons, striatal interneurons are quite evenly distributed 
within the striatum [41]. Most of them make synapses with 
striatal projection neurons and thus may be viewed as inter-
mediate relays between neuronal inputs from outside the 
striatum and striatal projection neurons. In turn, the striatum 
complex projects back upon the frontal lobe of the cortex via
direct and indirect topographically organized pathways those 
which pass through the thalamus to organize goal-oriented 
movements [3-7,24,67]. Both the direct and indirect path-
ways utilize the same neuronal cell type, namely the striatal 
spiny projection neuron that represents approximately 95 % 
of the neuronal population of the striatum [10,26,44,85]. 
Spiny output neurons are quite evenly distributed within the 
striatum complex and are both the major input targets, al-
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striatum. Their connections are thus the major determinant of 
the functional organization of the striatum. Striatal projection 
neurons all use the inhibitory neurotransmitter -aminobuty-
ric acid (GABA). Striatal output neurons of the “direct path-
way” project directly from the striatum to the substantia ni-
gra pars reticulata. In contrast, striatal output neurons of the 
“indirect pathway” connect the striatum to the substantia 
nigra pars reticulata via intermediate synaptic connections in 
the globus pallidus and the subthalamic nucleus. Projections 
from the striatum to the globus pallidus and from the globus 
pallidus to the subthalamic nucleus are GABAergic. Neurons 
originating from the subthalamic nucleus are glutamatergic, 
and project to the substantia nigra pars reticulata. Finally, the 
substantia nigra pars reticulata, the major outputput structure 
of the basal ganglia in rodents, sends GABAergic fibers to 
the thalamus, which in turn projects back to the motor cortex 
and other cortical area of the frontal lobe through excitatory 
glutamatergic fibers. 
  Despite the dual regulation of striatal output neurons by 
dopaminergic and glutamatergic inputs, there are very few 
axo-axonic synapses between glutamatergic and dopaminer-
gic terminals throughout the entire striatum complex [13,31, 
66,69,77]. Although this lack of axo-axonic synapses be-
tween glutamatergic and dopaminergic terminals limits the 
possibility of presynaptic interactions in a classical manner, 
Fig. (1). Basal Ganglia - Dorsal Pathways. 
The dorsal striatum receives cortical informations and transfer them to the output structures of the basal ganglia: the entopedoncular nucleus 
(EN) and the subtantia nigra pars reticulata (SNR) through the direct and indirect pathway. Then, the information is sent to the frontal cortex 
through the thalamus. STN: subthalamic nucleus; NAcc: Nucleus Accumbens; SNC: subtantia nigra pars compacta; Thal: Thalamus; RR:
retrorubral nucleus; GP: Globus Pallidus; VTA: ventral tegmental area. voie glutamatergique ; voie GABAergique; voie dopaminergique.
Fig. (2). Basal Ganglia - Ventral Pathways. 
The nucleus accumbens receives cortical informations and transfer them to the output structures of the basal ganglia: the entopedoncular 
nucleus (EN) and the subtantia nigra pars reticulata (SNR) through the direct and indirect pathway. Then, the information is sent to the fron-
tal cortex through the thalamus. STN: subthalamic nucleus; NAcc: Nucleus Accumbens; SNC: subtantia nigra pars compacta; Thal: Thala-
mus; RR: retrorubral nucleus; GP: Globus Pallidus; VTA: ventral tegmental area. voie glutamatergique ; voie GABAergique; voie dopa-
minergique. 134    Current Neuropharmacology, 2009, Vol. 7, No. 2 Hélène N. David 
dopamine and glutamate spilled over from the synaptic cleft 
modulate each other’s release through diffusion of neuro-
transmitters away from the synapse, leading to subsequent 
activation of extrasynaptic heteroreceptors through the so-
called volume neurotransmission [69,77], and further interact 
by modulating in concert the activity of striatal output neu-
rons. 
2. STRIATAL MOTOR INTERACTIONS BETWEEN 
GLUTAMATERGIC AND DOPAMINERGIC NEURO-
TRANSMISSION: CURRENT THINKING 
  The current thinking on striatal motor interactions be-
tween glutamatergic and dopaminergic neurotransmission 
has come mainly from the work of Albin et al. [3] and De-
Long [25] who first described a scheme, known as the model 
of basal ganglia, which was originally proposed to allow 
structuring glutamatergic and dopaminergic interactions in 
the dorsal striatum, i.e. the caudate and the putamen, as re-
gards to the production of locomotor activity and move-
ments. Due to its considerable success, this model has been 
adopted as a general principle and mode of reasoning and 
thinking as regards to glutamatergic and dopaminergic stri-
atal motor interactions. 
  According to the current thinking as regards to striatal 
motor function, activation by glutamate (Fig. 3) of the stri-
atal GABAergic output neurons that project directly to the 
substantia nigra pars reticulata (the striato-nigral output neu-
rons that form the direct pathway) is thought to provide a 
direct inhibitory action on the substantia nigra pars reticulata 
GABAergic neurons, the inhibition of which in turn leads to 
a disinhibition of the glutamatergic neurons involved in mo-
tor activities that project from the thalamus to the cortex; 
behaviorally, this allows the production of locomotor activity 
and movements. On the contrary, activation of the striato-
pallidal GABAergic output neurons, which project indirectly 
to the substantia nigra pars reticulata through a trisynaptic 
link and form the so-called indirect pathway, is believed to 
lead to an inhibition of the GABAergic neurons of the globus 
pallidus, thereby leading to a disinhibition of the subthalamic 
nucleus glutamatergic neurons and as a consequence to an 
activation of the subtantia nigra pars reticulata GABAergic 
neurons that project to the thalamus; overall, this provides an 
inhibitory effect on thalamo-cortical glutamatergic neurons 
involved in motor activities and thereby reduces the produc-
tion of locomotor activity and movements. Although the 
output activity of the basal ganglia is influenced by the op-
posing effects of glutamatergic neurotransmission at the di-
rect and indirect pathways, it is assumed that the direct 
pathway exerts a predominant control on locomotor activity. 
  Support for this model has been obtained from experi-
ments in non-human primates that have demonstrated that 
the activation of striato-nigral and striato-pallidal output neu-
rons, respectively, facilitate and suppress the production of 
motor activity and movements [4,5,25]. In addition, in ro-
dents, further support for the predominant role of striato-
nigral output neurons in the control of motor activity has 
been obtained from pharmacological studies that have con-
sistently shown that an intrastriatal injection of glutamate or 
glutamate receptor agonists in the caudate-putamen or the 
nucleus accumbens induces an increase in locomotor activity 
[11,12,14,15,20,22,23,27,34,36,48,64,68,71,72,75,82,86 but 
45,49,65]. However, leading to the conclusion that the role in 
the control of motor activity of glutamate inputs within the 
striatum is probably much more complex than that proposed 
by the model above, other studies have shown that the in-
trastriatal injection of glutamate receptor antagonists in the 
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caudate-putamen or the nucleus accumbens also results in an 
increase in locomotor activity [12,15,20,23,27,36,43,50,59, 
65,68,75,86 but 18]. 
  The model of basal ganglia organization and motor func-
tion also proposes that dopamine modulates glutamatergic 
inputs by exerting a dual effect on striatal GABAergic output 
neurons (Fig. 4): exciting striatal output neurons of the direct 
pathway, which mainly express D1-like receptors, and inhib-
iting striatal output neurons of the indirect pathway, which 
mainly express D2-like receptors. The segregation of D1-
like- and of D2-like postsynaptic receptors has provided the 
anatomical basis for the D1-like receptor-mediated excita-
tory effect of dopamine on striato-nigral neurons that form 
the direct pathway and the D2-like receptor-mediated inhibi-
tory action of dopamine on striato-pallidal neurons that con-
stitute the first synaptic link of the indirect pathway. Accord-
ing to the anatomical organization of the basal ganglia from 
the striatum complex to the motor cortex, the model predicts 
that activation of either D1-like receptors or D2-like post-
synaptic receptors leads to the production of locomotor ac-
tivity as follows: activation by dopamine of the striato-nigral 
GABAergic output neurons is thought to provide a direct 
inhibitory action on the substantia nigra pars reticulata 
GABAergic neurons. This inhibition in turn leads to a disin-
hibition of the glutamatergic neurons involved in motor ac-
tivities that project from the thalamus to the cortex and 
thereby to the production of locomotor activity and move-
ments. Alternatively, activation of the striato-pallidal 
GABAergic output neurons is believed to result in a dishi-
nibition of the globus pallidus GABAergic neurons, leading 
to a subsequent inhibition of the subthalamic nucleus gluta-
matergic neurons and to a reduction in activity of the subtan-
tia nigra pars reticulata GABAergic neurons that project to 
the thalamus. This inhibition in turn finally leads to a disin-
hibition of the glutamatergic neurons involved in motor ac-
tivities that project from the thalamus to the cortex and 
thereby to the production of locomotor activity and move-
ments. 
  A large body of evidence supports a functional synergy 
between D1-like and D2-like postsynaptic receptors that are 
mainly located on striato-nigral- and striato-pallidal output 
neurons, respectively [1,2,46,80,81,84]. At other times, acti-
vation of each dopaminergic receptor subtype produces an-
tagonistic effects [57]. Accordingly, the very vast majority of 
behavioral motor studies has shown: (i) activation by spe-
cific agonists of D1-like receptors results in an increase in 
locomotor activity [18,20-23,28,33,53,54,73,87 but 55,60]; 
(ii) co-activation of D1-like- and D2-like receptors – a phar-
macological condition shown to be required for the full ex-
pression of the postsynaptic effects of D2-like receptor ago-
nists because of the enabling role of D1-like receptors on 
D2-like postsynaptic receptor activation – results in synergis-
tic motor effects leading to a locomotor activity much more 
greater than that produced by the activation of D1-like recep-
tors alone, thought to be mainly mediated by D2-like post-
synaptic receptors [16,18,19,23,28,30,33,37,40,60] and re-
ported as such in the text below; (iii) activation in the cau-
date-putamen or the nucleus accumbens of D2-like receptors 
alone – a pharmacological condition thought to reflect 
mainly D2-like presynaptic receptor mechanisms [38,76,83] 
results at a very few exceptions [24] in a decrease in locomo-
tor activity [16,18,20-24,33,55,63,71,73 but 51,60]. In addi-
tion, support for the model of basal ganglia has been ob-
tained from studies that have consistently shown that block-
ade of dopaminergic receptors by intrastriatal infusion of 
D1-like and/or D2-like receptor antagonists resulted in a 
decrease in locomotor activity [35,53,58,60,78]. 
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  According to this model, simultaneous activation of glu-
tamatergic receptors and D1-like receptors within the stria-
tum complex should lead to a synergistic facilitatory action 
on locomotor activity through the direct striato-nigral path-
way, while activation of glutamatergic receptors and D2-like 
receptors should lead to antagonistic effects on locomotor 
activity through the indirect pathway. However, it is clear 
from the data summarized in Table 1, obtained from focal
injection studies performed in the caudate-putamen or the 
nucleus accumbens of “intact” animals, that an attempt to 
compel behavioral motor interactions between glutamatergic 
and dopaminergic neurotransmission into the current model 
of basal ganglia organization, and an exclusively excitatory 
role of glutamatergic neurotransmission, would fail to pro-
vide a reliable framework of functional interactions between 
both neurotransmitter systems in the striatum complex. 
3. TOWARDS A RECONCEPTUALIZATION OF 
FUNCTIONAL STRIATAL INTERACTIONS BET-
WEEN GLUTAMATERGIC AND DOPAMINERGIC 
NEUROTRANSMISSION AND THEIR ROLE IN THE 
PRODUCTION OF MOVEMENT 
  In this section, we will develop particular points that we 
believe to be important to layout by which glutamatergic and 
dopaminergic neurotransmissions may interact within the 
striatum complex to modulate striatal projection neurons and 
thereby the production of locomotor activity and movements 
in “intact” animals. Our analysis is based on an overview of 
previous published papers that have investigated in non-
lesioned animals functional interactions between glutamater-
gic and dopaminergic neurotransmission in the caudate-
putamen and the core of the nucleus accumbens using focal 
(intrastriatal) injection of glutamate and dopamine receptor 
ligands. Behavioral systemic injection studies with glutama-
tergic and dopaminergic neurotransmission were omitted 
intentionally because this technique is not without drawbacks 
since the pharmacological effects of systemic injection are 
diffuse, thereby altering many other brain structures that are 
involved in motor control throughout the brain.  
  Modulation by glutamatergic neurotransmission of loco-
motor responses produced by activation of dopaminergic 
postsynaptic receptors is in fact very heterogeneous and con-
trasts with the current model of basal ganglia striatal motor 
function, which assumes that glutamate exerts a facilitatory 
and an inhibitory action on locomotor activity through 
striato-nigral and striato-pallidal projection neurons respec-
tively. Based on the behavioral motor findings obtained from 
focal injection studies that are summarized in Table 1 and 
Table 1.  The Nucleus Accumbens: When Modelization Meets Experimental Research 
Effect of Glutamate Receptor Ligands on Locomotor Activity Produced by 
Dopamine Receptor Activation  
As Predicted 
by the bg Model 
Experimental Results  References 
NMDA receptor activation on D1-like receptor activation 
NMDA receptor blockade on D1-like receptor activation 
+
–
+
n.e. 
–
[23] 
[86] 
[23] 
NMDA receptor activation on D2-like receptor activation 
NMDA receptor blockade on D2-like receptor activation 
–
+
–
–
[23] 
[23] 
Non-NMDA receptor activation on D1-like receptor activation 
Non-NMDA receptor blockade on D1-like receptor activation 
+
–
–
–
n.e. 
[23] 
[23] 
[18] 
Non-NMDA receptor activation on D2-like receptor activation 
Non-NMDA receptor blockade on D2-like receptor activation 
–
+
+
–
[23] 
[23;40] 
Group I mGlu receptor activation on D1-like receptor activation 
Group I mGlu receptor blockade on D1-like receptor activation 
+
–
+
–
[63] 
[20] 
Group I mGlu  receptor activation on D2-like receptor activation 
Group I mGlu  receptor blockade on D2-like receptor activation 
–
+
–
n.e 
[63] 
[20] 
Group II mGlu receptor activation on D1-like receptor activation 
Group II mGlu receptor blockade on D1-like receptor activation 
+
–
+
n.e. 
[21] 
[21] 
Group II mGlu  receptor activation on D2-like receptor activation 
Group II mGlu  receptor blockade on D2-like receptor activation 
–
+
n.e. 
–
[21] 
[21] 
Group III mGlu receptor activation on D1-like receptor activation 
Group III mGlu receptor blockade on D1-like receptor activation 
+
–
–
+
[22] 
[63] 
Group III mGlu  receptor activation on D2-like receptor activation 
Group III mGlu  receptor blockade on D2-like receptor activation 
–
+
+
+
[22] 
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from other electrophysiological investigations [17], a more 
reliable and productive approach may be to fit the effects of 
glutamatergic neurotransmission into a modulatory, either 
facilitatory or inhibitory, role in a way that depends on the 
type of receptor involved. This proposal clearly breaks away 
from the current model of striatal motor function and the 
current theory about the role and function of glutamate, 
which is viewed as an excitatory neurotransmitter that pro-
duces activation of striato-nigral and striato-pallidal projec-
tion neurons. Though such a modulatory function of gluta-
matergic neurotransmission within the striatum complex may 
lead to heated debates and conflicts of opinion, there is now 
evidence that, depending on the type of receptor involved, 
activation of glutamatergic receptors can produce either a 
facilitatory or an inhibitory action (or have no action) on the 
locomotor responses produced by activation of dopaminergic 
postsynaptic receptors. Reciprocally, there is now a growing 
body of evidence that not only dopaminergic neurotransmis-
sion modulates glutamate release in the striatum, but that 
glutamatergic neurotransmission, depending on the type of 
receptor involved, also exerts a modulatory, either facilita-
tory or inhibitory, action on striatal dopamine release in ex 
vivo and in vivo models [24]. 
  If glutamate is considered as a neurotransmitter which 
activation can positively and negatively control both striato-
nigral and striato-pallidal output neurons, and in fine facili-
tate or inhibit the production of locomotor activity and 
movements mediated by D1-like receptor- or D2-like post-
synaptic receptor activation, it could be predicted that the 
types of receptors and glutamatergic pathway (e.g. from the 
prefrontal cortex, the hippocampus or the amygdala) acti-
vated would determine the direction in which functional in-
teractions between glutamatergic and dopaminergic neuro-
transmission occur. However, the mechanisms by which 
couplings of specific glutamatergic and dopaminergic recep-
tor subtypes occur cannot be foreseen with enough accuracy 
at this time, and only hypotheses can be drawn. Coupling 
possibilities may involve intracellular interactions on com-
mon neurons as well as spatial interactions through trans 
(poly)synaptic mechanisms. For example, co-activation of 
NMDA and D1-like receptors produces behavioral and elec-
trophysiological synergistic effects while co-activation of 
NMDA and D2-like receptors produces antagonistic effects. 
Consistent with intracellular mechanisms, it is well known 
that NMDA receptors and D1-like receptors tap into the 
same transduction system that is the adenosine monophos-
phate cyclic – phosphokinase A transduction system, while 
D2-like receptors inhibit it. Likewise, also consistent with 
intracellular mechanisms, activation of group III mGlu re-
ceptors inhibits the adenosine monophosphate cyclic – phos-
phokinase A transduction system and behaviorally opposes 
and favors the locomotor-activating properties of D1-like 
receptor activation and D2-like postsynaptic receptor activa-
tion, respectively. Another possibility is spatial interactions 
including volume neurotransmission and trans(poly)synaptic 
mechanisms, in which glutamatergic and dopaminergic re-
ceptors interact with each other distally. This possibility 
(Fig. 5) should be considered with particular interest when 
functional interactions between glutamatergic and dopa-
minergic neurotransmission do not fit with compatible intra-
cellular mechanisms, even if they do fit with the current 
model of striatal motor function. For example, co-activation 
of D1-like receptors and group II mGlu receptors produces 
behavioral motor synergistic effects as predicted by the cur-
rent model of basal ganglia motor function, but are respec-
tively positively and negatively linked to adenylate cyclase. 
Therefore, intracellular interactions between these receptors 
on common neurons do not appear tenable and spatial inter-
actions through volume neurotransmission mechanisms 
should have to be considered. Consistent with such mecha-
nisms, ultrastructural studies have shown that group II, in 
contrast with group I and group III, mGlu receptors have no 
Fig. (5). What can emerge from functional studies? 138    Current Neuropharmacology, 2009, Vol. 7, No. 2 Hélène N. David 
close apposition with synapses [74]. Likewise, co-activation 
of non-NMDA and D1-like receptors produces motor an-
tagonistic effects while co-activation of non-NMDA and D2-
like receptors produces synergistic effects. These effects do 
not fit with the current model of striatal motor function and 
the fact that non-NMDA, like NMDA, receptors produce 
postsynaptic excitatory currents at striatal output neurons 
[56]; therefore, the possibility that glutamatergic and dopa-
minergic neurotransmission interact spatially through trans 
(poly)synaptic mechanisms to modulate striatal projection 
neurons must be considered. The same principles of data 
analysis and interpretation are also applicable to blockade of 
glutamatergic receptors. In that way, the importance of in-
vestigating the effects of receptor blockade clearly has to be 
emphasized. Indeed, it is obvious from the data summarized 
in Table 1 that the effects produced by the activation or 
blockade of glutamatergic receptors on D1-like receptor- and 
D2-like pre- and postsynaptic receptor-mediated locomotor 
responses are not always reciprocal. This may be due to the 
fact that, for a given subtype of receptors, certain receptors 
are tonically activated while others are “silent” and can be 
phasically activated. Indeed, if a receptor is tonically actived, 
it cannot be further activated by a receptor agonist but can be 
blocked by a receptor antagonist; likewise, if a receptor is 
silent, it cannot be further blocked by a receptor antagonist 
but can be activated phasically by a receptor agonist. We 
propose that this may provide informations about the neuro-
anatomical localization within the striatum complex of the 
glutamatergic receptors studied, either on phasically acti-
vated neurons (PANs), such as the spiny output neurons that 
exhibit increases in firing in relation to movement, or on 
tonically activated neurons (TANs) such as the cholinergic 
interneurons that spike in a tonic and irregular fashion [9]. 
  Because all glutamatergic and dopaminergic receptor 
subtypes are expressed in striatal projection neurons, we 
believe that priority of interpretation must be given to intra-
cellular mechanisms. However, spatial mechanisms must 
also be considered whether or not intracellular mechanisms 
explain functional interactions between glutamatergic and 
dopaminergic neurotransmission. Doubtlessly, such a com-
plex combination of modulatory properties can no longer be 
regarded as a bulk system where glutamatergic inputs are all 
considered as excitatory. As a basis for an extended, but not 
yet complete, model of glutamatergic innervation of striatal 
output neurons, we propose that depending on their anatomi-
cal origin glutamatergic terminals may tap onto specific, and 
not all, glutamatergic receptor subtypes. Support for this are 
recent studies [62] that have shown that a reversible inhibi-
tion by the local anesthetic lidocaine of the prefrontal cortex, 
the hippocampus complex or the basolateral amygdala 
(which are brain structures that project glutamatergic fibers 
toward the striatum complex) has differential facilitatory and 
inhibitory effects on hyperlocomotion induced by activation 
in the nucleus accumbens of D1-like receptors or D2-like 
postsynaptic receptors that mimick those of glutamatergic 
receptor activation or blockade. 
  In addition, according to the current view as regards to 
dopamine-glutamate interactions in the striatum complex, 
glutamate is often seen as an excitatory neurotransmitter that 
is modulated by dopamine. However, in addition of the ex-
perimental evidence summarized in Table 1, there are neuro-
anatomical arguments to suggest that glutamate may be 
viewed on the contrary as a modulator, or better a driver, of 
dopaminergic neurotransmission (Fig. 6). Glutamatergic 
pathways that project to the striatum complex mainly origi-
nate from the whole cortex and limbic structures, such as the 
amygdala and the dorsal and ventral hippocampus. The cor-
tex and limbic structures are well known to play a key role in 
the processing of extrinsic (environmental) and intrinsic 
(emotional and mnesic) stimuli. Dopaminergic pathways that 
Fig. (6). Glutamate-coded inputs would allow tuning the intrinsic motor-activating properties of dopamine to adjust the production of loco-
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project to the dorsal and ventral striatum mainly originate 
from the substantia nigra pars compacta, the ventral tegmen-
tal area and retrorubral nucleus, which deeper brain struc-
tures are thought to be only slighly involved in the process-
ing of extrinsic and intrinsic stimuli compared to the cortex 
and limbic structures. Therefore, in contrast with the current 
thinking of a dopaminergic modulation of glutamatergic neu-
rotransmission, we propose that dopaminergic neurotrans-
mission should be seen as a subcortical-infralimbic motor 
pacemaker responsible for the basal and primary activation 
of striatal output neurons, and glutamate as a driver provid-
ing facilitatory and inhibitory inputs resulting from the proc-
essing of extrinsic and intrinsic stimuli by the cortical areas 
and limbic structures. These glutamate-mediated facilitatory 
and inhibitory inputs would allow modulating the motor-
activating properties of dopamine at striatal output neurons 
in order to transform and adjust the production of motor ac-
tivity into goal-oriented movements. As a result, the rele-
vance and accuracy of goal-oriented movements depend on 
the appropriate processing of extrinsic (environmental) and 
intrinsic (emotional and mnesic) stimuli; and this is the rea-
son why, for instance, strategic processes, perceptive aware-
ness, and learning influence goal-oriented movements. How-
ever, because infusion in the striatum complex of either glu-
tamate receptor agonists or antagonists consistently results in 
an increase of locomotor activity (see above), thereby indi-
cating phasic and tonic facilitatory properties of glutamater-
gic neurotransmission per se, it is likely that the direction of 
the glutamatergic modulation of dopaminergic neurotrans-
mission would depend on the level of the dopaminergic tone 
within the striatum complex. In other words, glutamatergic 
inputs would adapt their inputs as a function of outer and 
inner factors to the body to modulate dopaminergic neuro-
transmission and to produce accurate goal-oriented move-
ments.  
CONCLUSION 
  The principal function of oncoming glutamatergic and 
dopaminergic fibers that innerve the striatum complex is to 
modulate the activity and responsiveness of striatal output 
neurons. The present article emphasizes from a behavioral 
motor point of view the complexity of interactions between 
glutamatergic and dopaminergic neurotransmission, and fur-
ther propose a reconceptualization of these interactions in 
order to induce debate. Clearly, in the future, a great amount 
of research will be necessary to better define and understand 
intrastriatal interactions between these neurotransmitter sys-
tems. However, we believe that there is enough theroretical 
and empirical evidence to propose an extended, receptor and 
pathway-based, model of basal ganglia motor function, in 
which striatal dopaminergic neurotransmission can be seen 
as a motor pacemaker responsible for the basal and primary 
activation of striatal output neurons, and glutamate as a 
driver providing a multiple combination of tonic, phasic, 
facilitatory and inhibitory influxes resulting from the proc-
essing of extrinsic environmental and intrinsic emotional and 
mnesic stimuli. In this framework, and in contrast with the 
current thinking as regards to glutamate function, glutamate-
coded inputs would allow adjusting the intrinsic motor-
activating properties of dopamine in order to fine-tune the 
production of motor activity into goal-oriented movements. 
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